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INTRODUCTION
Digestive cancers are the most common malignant 
tumors worldwide, with three million new cases 
each year (30% of all cancers). The incidence of 
digestive cancers is constantly increasing, mainly 
due to trends in colorectal cancer. Epidemiologists 
have suggested that the environment (including life-
style factors) might play a profound role in maybe 
as many as 75% of all malignant tumors. There are 
striking variations in the risk of developing differ-
ent cancers between geographic areas. Most of the 
international variation is due to exposure to known 
or suspected risk factors related to lifestyle or envi-
ronment, and this provides a clear challenge in the 
field of prevention (P a r k i n  et al., 2002).
Nevertheless, there is convincing evidence of 
genetic predisposition for different malignant dis-
eases. While this is mainly related to polymorphism 
of tumor susceptibility genes – oncogenes and tumor 
suppressor genes – many investigations point to the 
significance of variability in genes whose indirect 
products can affect the risk of appearance of certain 
types of tumors, products such as blood group anti-
gens in man ( H a k o m o r i ,  1999;  L e  P e n d u 
et al., 2001;  F i j n e m a n ,  2005) .  Polymorphism 
of blood groups in human populations has been 
investigated in correlation with the appearance of 
certain types of tumors, the degree of malignancy, 
the response to therapy and survival ( H a k o m o r i , 
1999;  L e  P e n d u  et al., 2001) .  Most studies in 
this field are devoted to the ABH and RH antigen 
systems, which are known to be the most immuno-
genic and polymorphic human antigens.
Isoantigens of the human ABH system are repre-
sented by a variety of glycoproteins and glycolipids, 
the antigenic specificity of which is determined by 
variation in their constituent carbohydrate chains. 
These determinants are expressed on red blood 
cells, endothelial cells, and many normal epithelial 
cells, with wide spectra of different functions in cell 
physiology, fractions such as management of the 
structural integrity of membranes, cell adhesion, 
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and involvement in transfer of information among 
cells. The expression pattern of ABH antigens dras-
tically changes during normal cell development and 
during neoplastic cell differentiation (O k a d a  et 
al., 1987;  I s h i k a w a  et al., 1998;  N a k a g o e  et 
al., 2001). Also, previous investigations have shown 
a higher incidence of various types of carcinomas in 
individuals with blood groups A and B compared 
with those with blood group O (B e c k m a n  and 
A n g g v i s t ,  1987;  S l a t e r  et al., 1993; K o k i ć 
et al., 1996;  Yo u  et al., 2000; S u  et al., 2001; 
G u l e r i a  et al., 2005).
Contrary to ABH histo-blood antigens, Rh anti-
gens include very complex transmembrane proteins, 
so-called trimers composed of RhD/CcEe proteins 
and Rh-associated glycoproteins (RhAG), detected 
on erythrocyte membranes only. Recent investiga-
tions showed that Rh protein complexes could have 
a role as NH3 and CO2 transporters in mammals, 
placing them among the most significant key struc-
tural and functional molecules on erythrocyte mem-
branes ( K u r s t u  and I n w o o d , 2006). However, 
it is still not clear how the RhD (-) phenotype, in 
which synthesis of RhD protein is absent, could 
affect pathological processes of tumorogenesis. Rare 
investigations of the effect of Rh status on the 
appearance of different types of tumors, as well as 
the degree of survival, have provided no congruent 
results (H a l v o r s e n ,  1986; B r y n e  et al., 1991; 
S l a t e r  et al., 1993; M a n z o n i  et al., 2001).
The distribution of ABO and Rh blood groups 
varies geographically due to selection pressures and 
significant migrations of human populations (www.
bloodbook.com/world-abo.html). On Eurasian land, 
the frequency of phenotype A increases from East to 
West, while the frequency of phenotype B has the 
opposite trend. Thus, in East Asian countries (Japan, 
China, and India) the occurrence of blood group 
B is about 40%, while blood group A is present in 
frequencies of 20 to 30%. In contrast, in Europe the 
frequency of blood group A is the highest (about 
40%) while blood group B is present in 10 to 20% 
of the population [highest in Russia (23%), lowest 
in Scandinavia (10%)]. Blood group O has a fre-
quency of about 40%, with minor variations (www.
bloodbook.com/world-abo.html). Migrations on the 
Balkan Peninsula were significant during the past 
century, particularly in Bosnia and Herzegovina, 
which resulted in different frequencies of ABO and 
Rh genotypes and phenotypes in comparison with 
the neighborhood (B o š k o v i ć , 1966, 1975). 
In the last decade, numerous results were 
obtained which make clearer different functions of 
human blood groups and the biological meaning 
of their polymorphisms in normal and pathogenic 
cells (H a c o m o r i ,  1999; Va n  K i m  et al., 2006). 
Investigations on the predisposition for appearance 
of certain types of malignancies in relation to the 
ABH/Rh isoantigen systems have made a significant 
contribution to resolving these phenomena (B r y n e 
et al., 1981;  H a l v o r s e n ,  1986;  S l a t e r  et al., 
1993; S u  et al., 2001;  G u l e r i a  et al., 2005) .
The main aim of this investigation was to ascer-
tain whether there is any relationship between the 
appearance of certain types of tumors in the digestive 
tract and the ABO/Rh systems in a population from 
Bosnia and Herzegovina. In addition, we compared 
our results with those obtained for other populations 
in order to explore the possible influences of genetic 
background on these types of associations.
PATIENTS AND METHODS
Three hundred and fifty patients were registered ret-
rospectively in the Gastroenterohepatology Clinic, 
Clinical Center, University of Sarajevo over a discon-
tinuous period of 88 months (1987, 1988, September 
1992 – December 1995, 1997, and 1998). Seventy-
one cases were excluded from the study because 
the clinical evidence was not complete, so the total 
number of analyzed patients was 279. The following 
clinical data for each patient were included: sex, age, 
blood group (A, B, AB, O), Rh factor (D +/-), and 
localization of the primary tumor in the digestive 
tract (esophagus - EC, gastric - GC, duodenum - 
DC, colon - CC, rectum – RC, and liver - LC). 
Statistical analyses
The differences in ABO/Rh blood group dis-
tribution in patient groups and the general popu-
lation of Bosnia and Herzegovina (B o š k o v i ć , 
1965,  1975) as the control were assessed using the 
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Chi-square test. Student’s t-test was used to com-
pare average age values between sexes. Data were 
stored in a computer database and analyzed using 
Stastistica 6.0 software.
RESULTS
The average age of the studied patients with malig-
nant tumors of the digestive system was 59.5 years 
(range 3-90 years). There were no differences in 
mean age between the sexes (t = 0.08, n.s.). The 
incidence of digestive system cancer increased with 
age, beginning at 30 years but remained relatively 
low until the age of 50 years, after which it rapidly 
accelerated. The prevalence appeared to double with 
each successive decade until about the age of 70 
years. One fifth of the analyzed group was younger 
than 50 years.
In general, significantly more men (59.9%) than 
women (40.1%) suffered from malignant tumors of 
the digestive system (χ2 = 10.84; df = 1; p<0.001). 
The main reason was the prevalence of GC and LC 
among men. The frequency of GC was twice as high 
in men as in women (χ2 = 7.11; df = 1; p< 0.01). In 
the case of LC, the overall sex ratio (male:female) 
was around 1.5 in the analyzed group of patients 
(Table 1). 
The distribution of ABO blood groups in 
the studied group was not significantly different 
from that of the general population of Bosnia and 
Herzegovina (χ2 = 5.40, df = 3, p = 0.14). However, 
blood group B showed a significantly higher fre-
quency in the studied group (17.9%) than in the 
general population (14.3%, Table 2). 
There was no significant difference in the overall 
distribution of ABO blood groups between the ana-
tomic localizations of digestive system tumors.
The Chi-square test showed that men with the 
B/Rh(-) blood type became ill significantly more 
often than expected in relation to the general popu-
lation (χ2 = 19.45, df = 1, p<0.001). A similar trend 
was obtained in female patients, where women with 
A/Rh(+) became ill more rarely than expected (χ2 = 
4.29, df = 1, p<0.05).
Generally, the distribution of RhD phenotypes 
regarding tumor localization was not significantly 
different from that expected.
DISCUSSION
Comparing the obtained results with global cancer 
statistics on tumors in the digestive tract, we see that 
our population of patients had a similar gender ratio 
with a higher number of males and a similar average 
age with a rapid increase after 50 years old (A s h l y, 
1990;  P a r k i n  et al., 2002). 
Among the patients with malignancy in their 
digestive organs, we found the highest incidence of 
gastric cancer (38.35%). The incidence of LC and IC 
(duodenum, colon, and rectum) was approximately 
the same (27%, Table 1). This frequency of IC is 
half of the global frequency recorded in the popula-
tion-based cancer registry (http://www.iarc.fr). In 
addition, the frequency of IC in neighboring ethnic 
groups in the former Yugoslav Republics ranged 
from 55 to 61% of the analyzed types of tumors of 
the digestive system (http://www.iarc.fr). On the 
other hand, the frequency of LC in our population 
Table 1. Localization of malignant tumors in the digestive system in the examined group of patients (* p < 0.05, ** p < 0.01).
Localization of primary tumors Men (% of this sex) Women (% of this sex) All (% of total)
Esophagus 9  (5.4) 7 (6.3) 16 (5.7)
Stomach 73 (43.7)** 34 (30.4)** 107 (38.4)
Duodenum 1  (0.6) 2  (1.8) 3  (1.1)
Colon 24 (14.4) 24 (21.4) 48 (17.2)
Rectum 14 (8.4) 14 (12.5) 28 (10.0)
Liver 46 (27.5) 31 (27.7) 77 (27.6)
All 167 (59.9)** 112(40.1) ** 279
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was higher than the global frequency and the fre-
quency in neighboring ethnic groups (up to 10% of 
the analyzed types of digestive system tumors in the 
former Yugoslav Republics, http://www.iarc.fr). In 
the last two decades, the frequency of LC has rapidly 
increased due to increase and change in the preva-
lence of risk factors (for example, a higher incidence 
of chronic viral hepatitis) as well as changes in diag-
nostic techniques and in classification of the disease 
(Yu  et al., 2000;  M c G l y n n  and L o n d o n , 
2005).
The distribution of ABO blood groups in 
the studied group was not significantly different 
from that in the general population of Bosnia and 
Herzegovina, except for a significant difference in 
the frequency of patients with blood group B (Table 
2). Most studies have shown that individuals with 
blood group A or B have a slightly higher probability 
of developing cancer of the digestive system than 
blood group O individuals (A n n e s e  et al., 1990; 
S l a t e r  et al., 1993;  P a n d e y  et al., 1995;  Yo u  et 
al., 2000;  L e  P e n d u  et al., 2001;  S u  et al., 2001; 
G u l e r i a  et al., 2005).
The increased risk for developing cancers in 
individuals with blood group A may be attributable 
to expression of an „A-like antigen“(also called the 
Forssmann or Tn antigen). So-called „incompat-
ible A expression“ was detected in some types of 
gastric, liver, ovarian, colorectal and salivary gland 
cancer. Cancer cells of these tumors are capable of 
A antigen expression even in individuals with blood 
group B or O (O k a d a  et al., 1987;  H a k o m o r i , 
1999). Thus, antibodies to A can attack precancer-
ous and cancerous cells expressing this antigen. 
Individuals with blood groups A and AB lack anti-
bodies to A and so are more likely to develop these 
carcinomas (B e c k m a n  and A n g g v i s t ,  1987; 
H a k o m o r i ,  1999). According to other results, 
the protective effect of blood group O on cancer 
development can be ascribed to increased apoptosis 
resistance of epithelial cells presenting A and B anti-
gens (I c h i k a w a  et al., 1998,  Le P e n d u  et al., 
2001;  M a r i o n n e a u  et al., 2002). 
In our study group, we detected a significantly 
higher frequency of patients with the RhD(-) phe-
notype. Most authors have been unable to find any 
relationship between the Rh factor erythrocyte mem-
brane system of proteins and human cancerogenesis 
( M a n z o n i  et al., 2001) .  However, H a l v o r s e n 
(1986) showed significant differences in stage dis-
tributions of colorectal adenocarcinoma in RhD(+) 
and RhD(-) patients. S l a t e r  et al. (1993) ascer-
tained a significantly higher frequency of RhD(-) in 
groups of patients with colorectal tumors in early 
stages of development and with incurable tumors. 
Some research has suggested that the prognosis of 
survival for five years in RhD(+) patients is consid-
erably better than in RhD(-) patients ( B r y n e  et 
al., 1981) .
The effect of Rh phenotype in some pathological 
processes may be connected with the physiological 
role of very different and complex proteins of the Rh 
system in the transport of toxic biological gases such 
as ammonia or carbon dioxide to detoxifying organs, 
Table 2. Comparison of blood group frequency (ABO and Rh systems) in patients suffering from digestive tumors with frequencies 
in the wider population. (*data from B o š k o v i ć , 1965, 1975; * p < 0.05, ** p < 0.01).
ABO
blood  groups
Men (% of this sex)  Women (% of this sex)  All (% of total) Distribution in wider 
population  (%)
Group A 73 (43.7) 47 (42.0) 120 (43.0) (42.20)
Group B 32 (19.2) 18 (16.1) 50 (17.9)* (14.34)
Group 0 55 (32.9) 41 (36.6) 96 (34.4) (36.18)
Group AB 7 (4.2) 6  (5.4) 13 (4.7) (7.28)
Rhesus type
Rh(+) 133 (79.6) 91 (81.3) 224(80.3) (84.2)
Rh(-) 34 (20.4) 21 (18.8) 55 (19.7)* (15.8)
All 167 (59.1) 112(40.9) 279
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e. g. the liver or kidney ( Va n  K i m  et al., 2005; 
K u s t u  and I n w o o d ,  2006) .  Also, association 
of the RhD(-) phenotype with a higher frequency of 
cancer could be related to linkage disequilibrium. To 
be specific, the Rh gene locus is located on the short 
arm of chromosome 1 (1p36.2-1p34), where some 
oncogenes are also located, but linkage analysis for 
these genes is still unclear ( F e r r e l l  et al., 1989; 
R o l f e  et al., 2002) .
The effect of the RhD(-) phenotype was higher 
in male patients with blood group B (p< 0.01). In 
contrast, females with phenotype A/RhD(+) became 
ill significantly less than expected (p<0.05). Results 
showing important differences in the distribution 
of RhD phenotypes in relation to particular ABO 
blood groups are still rare and can depend on the 
examined malignancy and features of the investigat-
ed population. For example, in patients who suffered 
from pancreatic cancer, phenotype O/RhD(+) had a 
protective effect while AB/RhD(-) was a risk factor 
for endometrial carcinoma (K o k i ć  et al., 1996; 
A d a m i a n ,  2005) .  Since ABO(H) blood group 
genes map at 9q and Rh system genes map at 1p, 
genetic linkage between these two groups of genes is 
excluded (H a k o m o r i ,  1999). On the other hand, 
the influence of gender on the appearance of diges-
tive tumors with certain ABO/Rh status could issue 
from the very complex pathology of cancerogenesis, 
involving interactions of a huge number of environ-
mental, physiological, and genetic factors ( K e l l e y 
and D u g g a n ,  2 0 0 3 ;  F i j n e m a n ,  2005) .
Many reports have shown different associations 
of blood groups and the appearence of cancer based 
on geographical localization and ethnic qualifica-
tions (P a n d e y  et al., 1995;  Yo u  et al., 2000; 
G u l e r i a  et al., 2005). A protective effect for the 
O/Rh(+) phenotype was detected for pancreatic 
tumors in an ethnically close population in Serbia 
( K o k i ć  et al., 1996) .  In addition, blood group 
B was detected as a risk factor in the appearance of 
anaplastic thyroid cancer in Serbia ( Ž i v a l j e v i ć 
et al., 2008) .  However, besides genetic background, 
the complex etiology of tumorogenesis in the diges-
tive organs includes many environmental factors, 
such as cigarette smoking, dietary practices, alcohol 
consumption, infectious diseases like viral hepatitis 
or Helicobacter pylori, etc. ( K e l l e y  and D u g g a n , 
2003; Yu  et al., 2000) .  It follows that the effects of 
a particular genotype and/or phenotype, like the 
ABO/Rh system, should be investigated in more 
homogeneous groups in relation to the above-men-
tioned environmental risk factors ( Yu  et al., 2000; 
K e l l e y  and D u g g a n ,  2003) .
In conclusion, it can be asserted that the ABO 
and Rhesus systems contributed to a predisposition 
for appearance of malignant tumors in the digestive 
organs of the population studied.
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КРВНЕ ГРУПЕ ABO И RH СИСТЕМА У УЗОРКУ ОБОЛЕЛИХ ОД МАЛИГНИХ ТУМОРА 
ДИГЕСТИВНОГ ТРАКТА У БОСНИ И ХЕРЦЕГОВИНИ
СНЕЖАНА ЈОВАНОВИЋ-ЋУПИЋ1, ГОРАНА СТАМЕНКОВИЋ2, ЈЕЛЕНА БЛАГОЈЕВИЋ2,
Н. ВАНИС3, Б. СТАНОЈЕВИЋ1 и Љ. БЕРБЕРОВИЋ4
1Институт за нуклеарне науке ‘’Винча’’, 11000 Београд, Србија
2Институт за биолошка истраживања ‘’Синиша Станковић’’, 11060 Београд, Србија
3Клинички центар Универзитета Сарајево, 71000 Сарајево, Босна и Херцеговина 
4Универзитет у Сарајеву, 71000 Сарајево, Босна и Херцеговина
Анализирана је дистрибу­ција крвних гру­па 
ABO система и Резу­с фактора код 279 пацијената 
оболелих од малигних ту­мора дигестивног систе-
ма. Пацијенти су­ регистровани ретроспективно 
у­ Гастроентерохепатолошкој клиници Клинич-
ког центра Универзитета у­ Сарајеву­ у­ дисконти-
ну­итету­ током 88 месеци (1987−1998). На основу­ 
анализиране попу­лације пацијената закљу­чено 
је да: (а) му­шкарци значајно чешће обољевају­ од 
канцера желу­ца у­ односу­ на жене; (б) у­честалост 
карцинома јетре је три пу­та већа у­ поређењу­ са 
у­честалошћу­ овог обољења у­ свету­ и су­седним 
земљама; (ц) пацијенти са В крвном гру­пом и 
пацијенти са RhD(–) су­ у­ значајном степену­ 
чешћи у­ испитиваној попу­лацији оболелих од 
очекиваног.
